Xeris Biopharma Holdings Inc
Xeris Biopharma Holdings Inc (XERS) Historical Volatility
XERS 30-day historical volatility is 50%. This ranks in the 59th percentile of readings over the past year.
Read more
Tracking XERS historical volatility helps you see how much Xeris Biopharma Holdings Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Xeris Biopharma Holdings Inc's HV tells you what really happened. Use our scanner to monitor XERS 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The XERS 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Xeris Biopharma Holdings Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect.
The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Xeris Biopharma Holdings Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where XERS HV is running hot, cold, or in line. Make the XERS 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 28, 2026
As of September 28, 2026
See how volatility has moved over time
Track XERS historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→